thiophenes has been researched along with Long QT Syndrome in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Antzelevitch, C; Barajas-Martinez, H; Burashnikov, A; Cox, R; Demitrack, MA; Fossler, MJ; Kleiman, RB; Kowey, P; Kramer, M | 1 |
| Štuhec, M | 1 |
| Casal, M; Del Baño, F; Sarbu, MI; Supervía, A | 1 |
| Bentley, D; Jordan, P; Ruf, T; Russell-Yarde, F; Sturm, S | 1 |
| Arezina, R; Camm, AJ; Lorch, U; Naseem, A; Taubel, J; Wang, D | 1 |
| Borges-Gonzalez, S; Flockhart, D; Preskorn, SH | 1 |
1 review(s) available for thiophenes and Long QT Syndrome
| Article | Year |
|---|---|
Clinically relevant pharmacology of neuropsychiatric drugs approved over the last three years: Part II.
Topics: Anti-HIV Agents; Antidepressive Agents; Antiparkinson Agents; Apomorphine; Atazanavir Sulfate; Azabicyclo Compounds; Carbamates; Central Nervous System Agents; Cytochrome P-450 Enzyme System; Drug Approval; Drug Interactions; Duloxetine Hydrochloride; Furans; Humans; Hypnotics and Sedatives; Indenes; Long QT Syndrome; Mental Disorders; Oligopeptides; Organophosphates; Piperazines; Psychopharmacology; Pyridines; Sulfonamides; Thiophenes | 2006 |
2 trial(s) available for thiophenes and Long QT Syndrome
| Article | Year |
|---|---|
No evidence of QT prolongation with supratherapeutic doses of aleglitazar.
Topics: Adult; Aza Compounds; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Heart Rate; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Oxazoles; PPAR alpha; PPAR gamma; Quinolines; Thiophenes; Time Factors; Young Adult | 2012 |
Repeated supratherapeutic dosing of strontium ranelate over 15 days does not prolong QT(c) interval in healthy volunteers.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Aza Compounds; Bone Density Conservation Agents; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Female; Fluoroquinolones; Heart Rate; Humans; Linear Models; London; Long QT Syndrome; Male; Moxifloxacin; Nonlinear Dynamics; Organometallic Compounds; Patient Safety; Predictive Value of Tests; Quinolines; Risk Assessment; Risk Factors; Thiophenes; Young Adult | 2012 |
3 other study(ies) available for thiophenes and Long QT Syndrome
| Article | Year |
|---|---|
Intracellular uptake of agents that block the hERG channel can confound the assessment of QT interval prolongation and arrhythmic risk.
Topics: Analgesics, Opioid; Animals; Arrhythmias, Cardiac; Cell Line; Cricetulus; ERG1 Potassium Channel; Humans; Inhibitory Concentration 50; Long QT Syndrome; Membrane Transport Modulators; Quinidine; Spiro Compounds; Thiophenes; Tissue Distribution; Voltage-Gated Sodium Channel Blockers | 2021 |
Duloxetine-induced life-threatening long QT syndrome.
Topics: Antidepressive Agents; Arrhythmia, Sinus; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Long QT Syndrome; Middle Aged; Thiophenes | 2013 |
Duloxetine and hypothermia: possible summation of effect in QTc interval prolongation.
Topics: Antidepressive Agents; Duloxetine Hydrochloride; Female; Humans; Hypothermia; Long QT Syndrome; Middle Aged; Thiophenes | 2013 |